Tripeptide SQL Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/FJC.0000000000000269PMID 25923322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of Platelet Activation and Thrombus Formation Using a Pan-PI3K Inhibitor S14161

  2014cited by this paper
• Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitors.

  2014cited by this paper
• Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform.

  2013cited by this paper
• Purification and characterization of a novel antithrombotic peptide from Scolopendra subspinipes mutilans.

  2013cited by this paper
• L-Aminoacyl-triazine derivatives are isoform-selective PI3Kβ inhibitors that target non-conserved Asp862 of PI3Kβ

  2013cited by this paper
• Ferric chloride-induced murine carotid arterial injury: A model of redox pathology☆

  2013cited by this paper
• Novel antiplatelet drugs in clinical development

  2013cited by this paper
• Mechanisms of PI3Kβ-selective inhibition revealed by reciprocal mutagenesis.

  2013cited by this paper
• New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.

  2012cited by this paper
• A novel anti-platelet peptide (Z4A5) potential for glycoprotein IIb/IIIa inhibits platelet aggregation.

  2012cited by this paper
• Anopheline anti-platelet protein from a malaria vector mosquito has anti-thrombotic effects in vivo without compromising hemostasis.

  2012cited by this paper
• Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases

  2011cited by this paper
• Mechanisms underlying FeCl3‐induced arterial thrombosis

  2011cited by this paper
• The role of platelets in atherothrombosis.

  2011cited by this paper
• Purification and partial characterization of a novel phosphodiesterase from the venom of Trimeresurus stejnegeri: inhibition of platelet aggregation.

  2011cited by this paper
• The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs.

  2011cited by this paper
• Platelet adhesion to collagen.

  2011cited by this paper
• A novel platelet glycoprotein Ib-binding protein with human platelet aggregation-inhibiting activity from Trimeresurus jerdonii venom.

  2011cited by this paper
• ATVB in Focus Platelets Unplugged: Focus on Platelet Biology

  2010cited by this paper
• Antiplatelet and antithrombotic activities of salvianolic acid A.

  2010cited by this paper
• Platelet aggregation inhibitors from hematophagous animals.

  2010cited by this paper
• A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.

  2010cited by this paper
• Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3‐kinase

  2010influential reference
• Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.

  2010cited by this paper
• Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anti-coagulant drugs.

  2010cited by this paper
• Anti-atherogenic effects of centipede acidic protein in rats fed an atherogenic diet.

  2009cited by this paper
• Purification, characterization, and cDNA cloning of acidic platelet aggregation inhibiting phospholipases A(2) from the snake venom of Vipera lebetina (Levantine viper).

  2009cited by this paper
• Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

  2009cited by this paper
• Phosphoinositide 3-Kinase p110β Regulates Integrin αIIbβ3 Avidity and the Cellular Transmission of Contractile Forces*

  2009cited by this paper
• Role of platelets in atherothrombosis.

  2009cited by this paper
• Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.

  2008cited by this paper
• Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket.

  2008cited by this paper
• The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface area

  2008cited by this paper
• Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus

  2006cited by this paper
• PI 3-kinase p110β: a new target for antithrombotic therapy

  2005cited by this paper
• The Role of the Platelet in the Pathogenesis of Atherothrombosis

  2005cited by this paper
• PI 3-kinase p110beta: a new target for antithrombotic therapy.

  2005cited by this paper
• Phosphoinositide 3-kinases and the regulation of platelet function.

  2004cited by this paper
• Platelet-collagen interaction: is GPVI the central receptor?

  2003cited by this paper
• Class I phosphoinositide 3-kinases.

  2003cited by this paper
• Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo.

  2003cited by this paper
• Abciximab, Eptifibatide, and Tirofiban Exhibit Dose-dependent Potencies to Dissolve Platelet Aggregates

  2003cited by this paper
• Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred

  2002influential reference
• Insects and other arthropods used as drugs in Korean traditional medicine.

  1999cited by this paper
• Phosphoinositide 3-kinases: a conserved family of signal transducers.

  1997cited by this paper
• Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

  1996cited by this paper
• Effect of 1-Methyl-2-Mercapto-5-(3-Pyridyl)-Imidazole (KC-6141), an Anti-Aggregating Compound, on Experimental Thrombosis in Rats

  1978cited by this paper

• Vinculin Identified as a Potential Biomarker in Hand-Arm Vibration Syndrome Based on iTRAQ and LC–MS/MS-Based Proteomic Analysis

  2023cites this paper
• Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis

  2023cites this paper
• Novel Peptide Motifs Containing Asp-Glu-Gly Target P2Y12 and Thromboxane A2 Receptors to Inhibit Platelet Aggregation and Thrombus Formation.

  2022cites this paper
• One night of sleep deprivation induces release of small extracellular vesicles into circulation and promotes platelet activation by small EVs

  2022cites this paper
• Epigallocatechin-3-gallate exerts protective effect on epithelial function via PI3K/AKT signaling in thrombosis.

  2022cites this paper
• Synthesis and evaluation of novel and potent protease activated receptor 4 (PAR4) antagonists based on a quinazolin-4(3H)-one scaffold.

  2021cites this paper
• Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk

  2021cites this paper
• Purification and Characterization of Novel Collagen Peptides against Platelet Aggregation and Thrombosis from Salmo salar

  2020cites this paper
• A novel di-peptide Met-Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq-mediated signaling.

  2020cites this paper
• Inhibitory effects of hydrogen on in vitro platelet activation and in vivo prevention of thrombosis formation.

  2019cites this paper
• Synthesis and biological evaluation of BMS-986120 and its deuterated derivatives as PAR4 antagonists.

  2019cites this paper
• Antimicrobial Peptide Cathelicidin-BF Inhibits Platelet Aggregation by Blocking Protease-Activated Receptor 4

  2019cites this paper
• Antimicrobial Peptide Cathelicidin-BF Inhibits Platelet Aggregation by Blocking Protease-Activated Receptor 4

  2018cites this paper
• Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.

  2016cites this paper
• Centipede venoms as a source of drug leads

  2016cites this paper
• A tryptophan derivative TD-26 attenuates thrombus formation by inhibiting both PI3K/Akt signaling and binding of fibrinogen to integrin αIIbβ3.

  2015cites this paper